Nikko Asset Management Americas, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $10 Billion
- Q1 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 10,362,803 shares of RXRX stock, worth $80.9 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
10,362,803
Previous 9,203,780
12.59%
Holding current value
$80.9 Million
Previous $90.7 Million
13.85%
% of portfolio
1.03%
Previous 0.87%
Shares
12 transactions
Others Institutions Holding RXRX
# of Institutions
269Shares Held
193MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$192 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$188 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$125 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$96.2 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V711.9MShares$93 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.41B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...